Abstract
There are multiple published data showing that excessive oxidative stress contributes to bone loss and even bone tissue damage, and it is also correlated with the pathophysiology of bone degenerative diseases, including osteoporosis (OP). Garcinol, a polyisoprenylated benzophenone derivative, has been recently established as an anti-oxidant agent. However, it remains elusive whether Garcinol protects bone marrow mesenchymal stem cells (BMSCs) and bone tissue from oxidative stress-induced damage. Here, we explored the potential effects of Garcinol supplementation in ameliorating oxidative stimulation-induced dysfunction of BMSCs and bone loss in osteoporotic mice. In this study, we verified that Garcinol exerted potent protective functions in the hydrogen peroxide (H2O2)-induced excessive oxidative stress and dysfunction of BMSCs. Besides, Garcinol was also identified to improve the reduced bone mass and abnormal lineage commitment of BMSCs in the condition of OP by suppressing the oxidative stimulation. Subsequent analysis revealed that nuclear factor erythroid 2-related factor 2 (NRF2) might be a key regulator in the sheltering effects of Garcinol on the H2O2-regulated oxidative stress, and the protective functions of Garcinol was mediated by NRF2-antioxidant signaling. Collectively, Garcinol prevented oxidative stress-related BMSC damage and bone loss through the NRF2-antioxidant signaling, which suggested the promising therapeutic values of Garcinol in the treatment of oxidative stress-related bone loss. Therefore, Garcinol might contribute to treating OP.
Similar content being viewed by others
Introduction
Osteoporosis (OP), known as systemic bone metabolic disease, is primarily caused by insufficient bone formation. Nowadays, OP affects millions of patients globally, especially those after menopause and at old age [1, 2]. OP is topically accompanied by reduced bone mineral density (BMD), high risk in pathological fracture and deteriorated microstructure [3, 4]. Besides, OP is a global health concern and brings significantly increased economic burden to the society. As OP mainly occurs in populations aged 50 years old and above, the incidence of OP has been steadily raising, and the burden of OP is projected to be obviously larger due to the aging population globally [5, 6]. Therefore, developing preventable and treatable strategies is always the focus of OP treatment.
As we all know, the pathogenesis of OP is complex, and there are numerous risk factors resulting in bone loss and bone disorders, including aging and estrogen deficiency [7,8,9]. Recently, increasing evidences indicated that overproduced reactive oxygen species (ROS)-triggered oxidative stress is linked to the incidence and progression of OP [10,11,12]. In addition, the oxidative stress reduces the endogenous antioxidant defensive enzymes to induce dramatic damage to the cellular lipids, proteins, and nucleic acids, which is present throughout life [13,14,15]. Recently, multiple researches imply that oxidative stress, known as inducers of senescence, can induce bone loss and exert a negative role in bone remodeling and bone development [16]. For example, the sustained accumulation of oxidative stress is significantly increased in the condition of osteoporotic deterioration [17]. Besides, oxidative stress inhibits osteoblastic capacities, resulting in the impaired stemness of bone marrow mesenchymal stem cells (BMSCs). Generally, BMSCs are regarded as seed cells of osteoblasts and crucial components in the process of bone remodeling and thus play a pivotal role in the process of OP [18, 19]. Hence, blocking overproduced ROS and regulating oxidative stress are feasible strategies for OP treatment.
Nuclear factor erythroid 2-related factor 2 (NRF2) is recognized as a crucial and pivotal mediator of antioxidants [20, 21]. After oxidative stress stimulation, NRF2 transfers to the cell nucleus, binds to the antioxidant response element (ARE), and promotes the expression of antioxidant enzymes [21]. In addition, it was reported that Nrf2 deficiency led to the increase of ROS levels in mouse bone marrow cells, reduced trabecular BMD in femur, and then reduced cortical area of vertebrae [22]. Consequently, NRF2 might be an attractive candidate serving as a target of OP.
The antioxidant drugs exert obvious effects on the differentiation abilities and mineralization capacities of osteoblasts, and more importantly, they could be applied to ameliorate bone loss and OP [23, 24]. These evidences suggest that antioxidant drugs might be potentially used for the prevention of bone loss through counteracting the oxidative damage. Hence, natural antioxidants and its effective components have been subjects of increased research interest. Garcinol (camboginol), a well-known polyisoprenylated benzophenone, is mainly present in diverse Garcinia species. Garcinol has been immensely valued for its numerous medicinal values, such as antioxidant, acetyltransferase inhibitory, and anti-cancer effects [25, 26]. Recent researches have stated that Garcinol suppressed the receptor activator of nuclear factor (NF)-kB-ligand (RANKL)-caused osteoclastic formation by regulating MAPK and PI3K-AKT, which demonstrated that Garcinol could be applied as the focus in treating bone-related disorders [27]. However, the effects and molecular mechanisms of Garcinol in oxidative stress-induced bone loss need to be further investigated.
In this study, Garcinol, as an antioxidative drug, was revealed to attenuate the oxidative stress-induced BMSC dysfunction and bone loss. Based on this, the underlying mechanism and application potentials of Garcinol for OP therapy would be further verified in this research.
Results
Garcinol protects oxidative stress-induced dysfunction of BMSCs
Based on previous reports, hydrogen peroxide (H2O2) was widely applied to induce oxidative stress in different cells [28,29,30,31,32]. Hence, BMSCs were pretreated with H2O2 at 100 μM for 2 h to establish the oxidative stress-treated cell models, and the establishment of this model laid the groundwork for further analysis of the Garcinol functions. Some reports have speculated that oxidative stimulation might be responsible for regulating the biological functions of BMSCs. Thus, we then investigated whether different concentrations of Garcinol could inhibit the elevated ROS level in H2O2 stimulation-induced BMSCs. The results reflected that H2O2 treatment effectively activated ROS production in BMSCs, which was gradually reversed by Garcinol (Fig. 1A, B). Besides, 10 μm Garcinol exhibited the best effect among all drug intervention group (Fig. 1B).
To fully depict the specific effects of Garcinol on ROS-mediated injury, the role of Garcinol in the viability and survival of BMSCs was detected first. We investigated the major roles of various concentrations of Garcinol in the cell viability of BMSCs after treatment with H2O2 at 100 μM for 2 h. As indicated in Fig. 1C, the cell viability of BMSCs was notably descend after H2O2 administration, while it was gradually improved after the treatment of Garcinol from 2.5 to 10 μM (Fig. 1C). Notably, the protective role of Garcinol was the best when the concentration reached 10 μM (Fig. 1C). The trypan blue exclusion assay was further carried out to explore the roles of Garcinol in the ROS-induced cell death. The results validated that Garcinol treatment decreased the cell mortality in H2O2-induced BMSCs in a concentration-dependent manner (Fig. 1D). Then, the protection of Garcinol against oxidative stress-caused apoptosis of BMSCs were assessed. The outcomes of TUNEL staining denoted that Garcinol at 2.5, 5, 7.5, 10 μM obviously diminished the percentage of apoptotic BMSCs induced by H2O2 treatment, indicating that H2O2-induced cell death might be mainly caused by apoptosis, and it could be mitigated by Garcinol treatment (Fig. 1E, F). All in all, Garcinol was proved to alleviate the oxidative stress-reduced cell viability, cell death and apoptosis of BMSCs. Therefore, Garcinol was able to reverse oxidative stress-induced BMSC injury and restore the dysfunctions of BMSCs.
Garcinol alleviates oxidative stress-caused abnormal fate determination of BMSCs
In order to characterize the specific functions of Garcinol in H2O2-induced abnormal fate of BMSCs, H2O2 was applied to induce intracellular oxidative stress in BMSCs, and Garcinol from 2.5 to 10 μM was applied to treat BMSCs. The capacity of osteogenesis, which was indicated by calcified nodules, was identified by alkaline phosphatase (ALP) and alizarin red S (ARS) staining (Fig. 2A, B). The results of ALP and ARS staining indicated that the number and area of mineralized nodules of BMSCs were markedly decreased after H2O2 stimulation, while gradually elevated upon different concentrations of Garcinol treatment (Fig. 2A, B). Furthermore, compared with H2O2 group, the mRNA levels of the well-known osteoblast-specific genes, including ALP, bone morphogenetic protein 4 (BMP4) and runt-related transcription factor 2 (Runx2), were obviously increased in the Garcinol group (Fig. 2C). Considering these results, we supposed that Garcinol restored the oxidative stress-caused weakened osteogenic differentiation of BMSCs.
To elucidate the possible functions of Garcinol in the adipogenesis, BMSCs were separately treated by H2O2 and varying concentrations of Garcinol, then cultured in the adipogenesis differentiation medium. The analysis of oil red O (ORO) staining demonstrated that Garcinol retarded H2O2-stimulated facilitation in the lipid droplet formation of BMSCs (Fig. 2D). Consistently, the results were also comfirmed by qRT-PCR assay. As depicted in Fig. 2E, the levels of critical markers of adipocyte differentiation, including peroxisome proliferator-activated receptor γ (PPARγ), fatty-acid-binding protein 4 (Fabp4) and CCAAT enhancer-binding protein α (C/EBPα), were significantly heightened by H2O2-caused oxidative stress, while markedly blocked by Garcinol treatment (Fig. 2E). The above findings indicated that Garcinol rescued the H2O2-induced abnormal differentiation tendency of BMSCs.
Garcinol restores the oxidative stress and bone loss in osteoporotic mice
OP has been recognized of being always accompanied with increased oxidative stress and accumulation of ROS [33,34,35,36]. Thus, the bilateral ovariectomy (OVX) mouse models were utilized to estimate the protective effect of Garcinol on OP and oxidative stress-induced injury in vivo. According to subsequent analysis, OVX mice displayed significant damaged architecture of trabecular bones in the distal femurs, confirming that there was an obvious reduction in bone mass in OVX-related osteoporotic mouse models (Fig. 3A). Moreover, Garcinol-treated OVX mice also showed evident improvements in architecture of trabecular bones in the distal femurs in osteoporotic mice, indicating that Garcinol restored the bone loss in osteoporotic mice (Fig. 3A). Similarly, further analysis of microcomputed tomography (μCT) scanning indicated that BV/TV, Tb.N, Tb.Th and BMD were evidently lessened, accompanied by increased Tb.SP and structure model index (SMI) in ovariectomized mice relative to the CTL group (Fig. 3B). Furthermore, compared with OVX group, a higher BV/TV, Tb.N, Tb.Th and BMD and a lower Tb.SP and SMI could be observed in OVX mice after Garcinol treatment, suggesting that Garcinol effectively restored the OVX-induced deterioration of microstructure in osteoporotic mice (Fig. 3B).
Additional analysis of ROS revealed that, compared with the BMSCs from the CTL group, the OVX group exhibited a markedly elevated ROS level, which indicated a remarkable oxidative capability (Fig. 3C). However, the increased ROS level was effectively mitigated in the OVX mice administered with Garcinol (Fig. 3C). Besides, in contrast to CTL group, the BMSCs from OVX group showed an obvious reduction in superoxide dismutase (SOD) activity, that represented the antioxidative ability (Fig. 4D). Interestingly, the decreased SOD level in osteoporotic mice were partially restored by Garcinol administration, implying that Garcinol treatment could block the elevated oxidative stress level in BMSCs from OP (Fig. 4D). The above findings demonstrated that Garcinol restored the oxidative stress-related bone loss in mice with OP.
Garcinol attenuates the abnormal lineage commitment of BMSCs in osteoporotic mice
Based on the fact that OP-impaired bone-fat balance might be strongly correlated with oxidative stimulation, we detected the roles of Garcinol in cell fate of BMSCs under osteoporotic conditions. Next, to further gain insight into the beneficial functions of Garcinol in OP, the BMSCs of mice from different groups were isolated, respectively. Then, the fate shift between adipocytes and osteoblasts of BMSCs were determined. As exhibited in Fig. 4A, B, the matrix mineralization of BMSCs was markedly less in OVX-caused osteoporotic mice than CTL group (Fig. 4A, B). In addition, compared with OVX group, a significant higher osteoblastic ability could be observed in BMSCs from OVX + 10 mg/Kg Garcinol group and OVX + 20 mg/Kg Garcinol group (Fig. 4A, B). In addition, the relative mRNA levels of important osteoblastic markers, including ALP, BMP4 and Runx2, were statistically decreased in BMSCs derived from OVX group, while the decreased expression levels of these genes were upregulated by Garcinol supplementation (Fig. 4C). Furthermore, the adipogenesis of BMSCs after stimulation with different treatment was further estimated through additional experiments. As a result, the formation of oil droplets was significantly promoted in BMSCs derived from the OVX group (Fig. 4D, E). After Garcinol treatment, the enhanced adipogenic abilities of BMSCs from OVX mice was abolished, suggesting that the adipocyte formation of BMSCs in osteoporotic mice could be hampered by Garcinol (Fig. 4D, E). Furthermore, the mRNA expression of adipocyte specific genes was found to be higher in BMSCs from OVX mice than that from CTL group (Fig. 4F). However, Garcinol treatment decreased the expression of PPARγ, Fabp4 and C/EBPα in the BMSCs from OVX + 10 mg/Kg Garcinol group and OVX + 20 mg/Kg Garcinol group (Fig. 4F). Overall, Garcinol might restore the bone loss by repairing the disturbed differentiation of BMSCs from oxidative stress-related OP.
NRF2 may act as a key regulator in the process of Garcinol improving H2O2-induced oxidative stress
Subsequently, an exploration was performed on the potential mechanisms of Garcinol in ameliorating oxidative stress-contributed injury of BMSCs. Given the important roles of NRF2 in preventing oxidative stress-induced damage, NRF2 was selected for additional analysis. The BMSCs were incubated with H2O2 at 100 μM and Garcinol at 10 μM, respectively, and the relative mRNA expression of NRF2 in BMSCs were evaluated. As displayed in Fig. 5A, the relative expression level of NRF2 was significantly down-regulated in BMSCs after H2O2 administration, while it was reversed by Garcinol treatment (Fig. 5A). Furthermore, the protein levels of NRF2 were notably declined in BMSCs after H2O2 supplementation, but the declined NRF2 protein level was partly recovered by Garcinol treatment (Fig. 5B, C).
Considering NRF2 might be a crucial regulator in mediating the protections of Garcinol in the H2O2-induced oxidative stress, the expression of NRF2 was significantly decreased after knockdown of NRF2 by using siRNA-NRF2 in BMSCs, and we further tested the role of NRF2 in H2O2-induced oxidative stress of BMSCs (Fig. 5D). The results of intracellular ROS measurement assays expounded that Garcinol could obviously inhibit H2O2 treatment-stimulated elevated ROS level in BMSCs, while the impact was blocked after transfection with siRNA-NRF2 (Fig. 5E). Additional experiments determined the importance of NRF2 in the functions of Garcinol against H2O2-induced oxidative stress (Fig. 5F). The results of the SOD detection assay revealed that knockdown of NRF2 appeared to reverse the inhibitory ability of Garcinol in H2O2-caused oxidative stress (Fig. 5F). Hence, we hypothesized that NRF2 could regulate the protective effects of Garcinol on the oxidative stress-induced damaged BMSCs.
Garcinol possesses the protective activities against oxidative stress via NRF2-antioxidant signaling
To further confirm the crucial role of NRF2 in the inhibitory effects of Garcinol in H2O2-induced oxidative stress and abnormal functions of BMSCs, the biological functions and lineage commitment of BMSCs were then tested. The BMSCs were supplemented with H2O2 at 100 μM and Garcinol at 10 μM, respectively, and then transfected with siRNA-NRF2 for subsequent experiments. The data from CCK-8 assay displayed that the diminished cell viability caused by H2O2 treatment was recovered by Garcinol, and such effect could be blocked by knock-down of NRF2 (Fig. 6A). Based on the outcomes of trypan blue exclusion assay, compared with H2O2 group, the cell death was reduced in the BMSCs from H2O2+Garcinol group while apparently raised in the H2O2+Garcinol+siRNA-NRF2 group, suggesting that NRF2 was indispensable for the protection of Garcinol against H2O2-induced cell death. (Fig. 6B). Besides, the qualitative analysis of TUNEL staining indicated that the increased percentage of apoptotic BMSCs induced by H2O2 was attenuated after Garcinol treatment, while it was remarkably reversed by silencing NRF2 (Fig. 6C).
Next, ARS, ALP staining and ORO staining were carried out to assess the functions of NRF2 in Garcinol-mediated specific effects in the H2O2-induced abnormal fate of BMSCs. On basis of the staining results, Garcinol contributed to an apparent protection in the osteogenic-adipogenic imbalance of BMSCs caused by H2O2-induced oxidative stress, while the protective ability was partly blocked by deletion of NRF2 (Fig. 6D–F). Such findings provided important evidence for the importance of NRF2 in the protective activity of Garcinol in the oxidative stress-induced abnormal cell fate of BMSCs (Fig. 6D–F). Collectively, Garcinol exerted protective effects against oxidative stress-induced abnormal functions of BMSCs via the NRF2-antioxidant signaling.
Discussion
Garcinol, a polyisoprenylated benzophenone, is well-known as an antioxidant [37,38,39]. Chang et al. illustrated that Garcinol had the potentials to prevent and attenuate dysfunction of cardiomyocytes through suppressing the apoptosis and inflammation [40]. Kim et al. revealed that Garcinol efficiently attenuated the excessive oxidative stress and apoptosis in cisplatin-treated tubular epithelial cells [41]. In this study, the functions of Garcinol in oxidative stress-induced injury of BMSCs were investigated through establishing the models of H2O2-stimulated BMSCs. The investigation results revealed that administration of Garcinol ameliorated H2O2-caused reduction in cell viability, increase in cell death and apoptosis of BMSCs by inhibiting excessive oxidative stress, indicating the protective functions of Garcinol in H2O2-associated dysfunction of BMSCs. Our research further supported the prevention of Garcinol in the H2O2-caused imbalanced fate shift of BMSCs between osteoblasts and adipocytes. Also, administration of Garcinol could restored the abnormal cell fate of BMSCs caused by excessive oxidative stress. As now, our research first revealed the protective roles of Garcinol in oxidative stress-caused injury and dysfunction of BMSCs.
Oxidative stress participates in the progression of OP, including impaired bone remodeling, bone ageing and deterioration of microstructure [42,43,44]. Antioxidants have been broadly considered as potent agents for bone loss and OP [45,46,47]. Therefore, we focused on antioxidants and determined the protective functions of Garcinol in excessive oxidative stress and bone tissue damage. In our study, excessive oxidative stress could be observed in osteoporotic mice, implying that excessive oxidative stress was closely involved in the pathogenesis of OP. Additional analysis supported that supplementation of Garcinol not only restored the abnormal cell fate decision of BMSCs but also rescued the osteoporotic phenotype in the osteoporotic mice by inhibiting excessive oxidative stress. To date, we first focused on the functions of Garcinol on excessive oxidative stress-associated dysfunctions of BMSCs and bone loss, laying the foundation for the future utilization of Garcinol to relieve oxidative stress-related bone tissue damage in osteoporotic patients.
What’s more, we also demonstrated an in-depth mechanism for inhibition of excessive oxidative stress by Garcinol. Our study revealed that Garcinol might exert an antioxidant role in H2O2-related injury of BMSCs and osteoporotic mice through a vital regulator NRF2. NRF2, a master transcription factor for stress response, possesses the ability to manipulate the cellular defense against toxic and oxidative insults by modulating the expression level of antioxidant and detoxification genes [48,49,50]. Mechanistically, to explore the role of NRF2 in Garcinol-mediated protective roles, BMSCs were transfected with siRNA-NRF2 to reduce the level of NRF2. The results indicated that knockdown of NRF2 appeared to deteriorate the inhibitory ability of Garcinol in the H2O2-caused oxidative stress. According to these results, we highlighted the importance of NRF2 in the protection function of Garcinol in the H2O2-induced oxidative stress. Furthermore, this research also exhibited that Garcinol exerted protective effects against oxidative stress-induced dysfunction of BMSCs and bone loss via the NRF2-antioxidant signaling. This study has elucidated the importance of NRF2 in Garcinol-mediated protective functions in excessive oxidative stress-induced injury for the first time.
Although there were some novel findings in our study, it needs to be acknowledged that there are also certain limitations. Firstly, the current study has not fully explained the detailed mechanism of NRF2 in Garcinol-mediated protection against oxidative stress. Secondly, the impact of Garcinol on the downstream targets of NRF2 is also unclear. Furthermore, the effect of Garcinol on NRF2 was not assessed in vivo. Further research and exploration are still required to solve these issues. In addition, our study probed into the functions of Garcinol based on restoring excessive oxidative stress-induced dysfunction and abnormal cell fate of BMSCs, however, the role of Garcinol in excessive oxidative stress-induced bone formation and bone resorption remains to be determined. Future functional investigation will explore the anti-oxidative stress effect of Garcinol on osteoblasts. Moreover, we did not evaluated the toxicity and side effects of Garcinol to BMSCs or mice in vitro and in vivo. Hence, the focus of future observation is to investigate the toxicity and side effects of Garcinol.
To sum up, our research revealed that Garcinol could prevent oxidative stress-induced dysfunction and abnormal cell fate of BMSCs, and subsequently ameliorate bone disorders in osteoporotic mice via activating NRF2-antioxidant signaling (Fig. 7). This study provided convincing evidence that Garcinol might be developed as a potent and promising candidate medicine in the treatment of OP and other bone disorders correlated with oxidative stress in the future. The eventual application of Garcinol in osteoporotic patients is of great significance and worthy of further clinical investigation.
Materials and methods
Cell isolation and cell culture
The mouse BMSCs were separated from the bone marrows of bilateral femur in 8-week-old C57BL/6 J mice in accordance with the previous study [51]. BMSCs were maintained in BMSC culture medium (Cyagen Biosciences, China) and placed in a standard culture environment. The fresh culture medium was replaced every other day. When the final density of BMSCs was closed to 90%, the cells were digested under the action of 0.25% trypsin (Cyagen Biosciences, China) and then sub-cultured for further analysis.
Cell treatment
BMSCs were treated with H2O2 (Sigma-Aldrich, USA) at 100 μM for 2 h to induce the intracellular oxidative stress [28, 52, 53], followed by treatment with Garcinol (2.5, 5, 7.5, 10 μM) for 48 h.
Intracellular ROS measurement
The intracellular ROS levels of BMSCs were determined according to the previous reports [54]. In brief, the BMSCs were washed three times using PBS buffer and then incubated with the diluted DCFH-DA fluorescent probe at 37 °C in the dark for 20 min. Next, the cells were rinsed by FBS-free cell culture medium three times. Finally, the absorbance at 488 and 525 nm was analyzed through a SpectraMax EM Microplate Reader (Molecular Devices, USA), followed by the calculation and analysis of the ROS levels.
Detection of cell viability
The CCK-8 assays were carried out to identify the cell viability in BMSCs. Briefly, BMSCs were seeded in 96-well plates (Nest, China) at a final density of 5000/well. When the cell confluence reached 90%, the culture medium was added with Garcinol or H2O2, and the cells were pre-incubated with 10-μL CCK-8 solution (Tongren, Japan). After 4 h, the optical density (OD) of cells were identified through a microplate reader (TECAN, Switzerland) at 450 nm.
Trypan blue exclusion assay
The death of BMSCs was estimated by trypan blue exclusion assay. Firstly, BMSCs were seeded in six-well plates and cultured for one day. After that, the cells were detached in the presence of EDTA solution (Beyotime Biotechnology, China) and then maintained in trypan blue solution. After 3-5 min of staining, the number of live and dead BMSCs was automatically analyzed using an automated cell counter (Thermo, USA).
Apoptosis assay
The apoptotic BMSCs were analyzed utilizing an in-situ Cell Death Detection Kit (Roche, USA) based on the manufacturer’s manuals. The TUNEL-positive cells were viewed through a fluorescence microscope (Nikon, Japan), and the pictures of apoptotic BMSCs were captured.
Alkaline phosphatase (ALP) staining
The osteoblastic formation and mineralization abilities of BMSCs after osteogenesis for 7 days were detected by ALP staining. To assess the osteoblastic formation, the BMSCs seeded in 24-well plates (Nest, China) were continuously maintained in osteogenic induction medium (Cyagen Biosciences, China) under differentiating conditions. After osteogenesis for continuous 7 days, the mineralization of the calcium nodules was observed through ALP staining by using ALP staining kits (CTCC Bioscience, China). The stained BMSCs were subsequently visualized using an invert light microscope (Nikon, Japan), followed by the capture of representative images. To visualize the osteoblastic activity of BMSCs, the stained mineralization was dissolved by 10 mM p-nitrophenyl phosphate (Thermo, USA), and then the OD values at 420 nm were measured and calculated.
Alizarin Red S (ARS) staining
The accumulation of calcium deposition of BMSCs after osteogenesis for 14 days was ascertained via ARS staining. Specifically, the cells were fixed in 4% PFA then incubated with ARS staining kits (Cyagen Biosciences, China) for about 30 min. Next, the cells were rinsed by PBS and visualized under an invert light microscope (Nikon, Japan), and the representative images were captured. To quantify the calcium deposition, the stained mineralized bone nodules were dissolved using 10% cetylpyridinium chloride (Sigma, USA), and the OD values were visually seen at 570 nm under a microplate reader (TECAN, Switzerland).
Quantitative real-time polymerase chain reaction (qRT-PCR)
TRIzol reagents were used for extracting the total RNAs from BMSCs, and the complementary DNAs (cDNAs) were synthesized through PrimeScript RT reagent Kits (Takara, Japan). The amplification of cDNAs was routinely performed by qRT-PCR analysis using SYBRGreen Mix (Takara, Japan). The GAPDH was considered as a housekeeping gene for measuring the expression of target genes by the comparative 2−△△Ct method. The primer sequences were listed in Table 1.
Oil Red O (ORO) staining
ORO staining was conducted to identify the adipogenic committed cells. Briefly, the BMSCs were fixed using 4% PFA solution, dyed with ORO solution (Cyagen Biosciences, China) for 30 min, and then observed through an inverted light microscopy (Nikon, Japan). Finally, the representative images were acquired and the number of adipocytes was obtained.
Animal experiments
A total of 40 female C56BL/6J mice aging 6–8 weeks were provided by Beijing Vital River Laboratory Animal Technology Co., Ltd. The mice were randomly divided into following four groups: CTL group, OVX group, OVX + 10 mg/Kg Garcinol group and OVX + 20 mg/Kg Garcinol group. After an acclimatization period of one week, the mice in OVX group underwent bilateral ovariectomy (OVX) according to a previous study [4]. While, the mice in CTL group were subjected to sham operation. The osteoporotic mouse models received drug treatment four weeks after surgery.
The mice from OVX + 10 mg/Kg Garcinol group and OVX + 20 mg/Kg Garcinol group were given intraperitoneal injection of Garcinol (10 mg/Kg or 20 mg/Kg) for 14 consecutive days [26, 55,56,57]. The mice in CTL and OVX group were intraperitoneally injected with normal saline. After completion of experiments, the femurs of mice were obtained and subject to μCT analysis. The trabecular structural parameters and SMI were analyzed. All procedures were approved by the Ethics Committee of the First Affiliated Hospital of Harbin Medical University (2022071).
Measurement of oxidative stress
The level of MDA was separately analyzed through colorimetric/fluorometric assay kits (Sigma, USA) as instructed by the manufacturers.
Cell transfection
To generate NRF2 knock-down cells, the BMSCs were transfected with short interfering RNAs (siRNAs) targeting Nrf2 (siRNA-NRF2) or negative controls (siRNA-NC, Riobio, Guangzhou) by Lipofectamine 2000 reagents (Invitrogen, USA) following the manufacturer’s instructions.
Western blot (WB) assay
The cells were obtained and lysed in RIPA buffer (Beyotime, China) at 4 °C. Western blot assays were carried out as mentioned previously [58]. The following antibodies used in the present study were obtained from Abcam (NRF2) and Cell Signaling Technology (β-actin). The immuno-reactive bands were analyzed by enhanced chemiluminescence (ECL) and then calculated by Image Software (NIH, USA).
Statistical analysis
The data were shown as mean ± standard deviation (SD). The statistical analysis was conducted by SPSS 20.0 software (SPSS, Chicago, USA). Analyses were performed by one-way ANOVA or Student’s t-test. P < 0.05 indicated a significant difference.
Data availability
The datasets generated and analyzed during the current study are available from the corresponding author upon reasonable request.
References
Liu F, Yuan Y, Bai L, Yuan L, Li L, Liu J, et al. LRRc17 controls BMSC senescence via mitophagy and inhibits the therapeutic effect of BMSCs on ovariectomy-induced bone loss. Redox Biol. 2021;43:101963.
Gao M, Zhang Z, Sun J, Li B, Li Y. The roles of circRNA-miRNA-mRNA networks in the development and treatment of osteoporosis. Front Endocrinology. 2022;13:945310.
Li M, Cong R, Yang L, Yang L, Zhang Y, Fu Q. A novel lncRNA LNC_000052 leads to the dysfunction of osteoporotic BMSCs via the miR-96-5p-PIK3R1 axis. Cell Death Dis. 2020;11:795.
Li Y, Hao W, Guan J, Li B, Meng L, Sun S, et al. Relationship between indices of circulating blood cells and bone homeostasis in osteoporosis. Front Endocrinol. 2022;13:965290.
Li Y, Meng L, Zhao B. The roles of N6-methyladenosine methylation in the regulation of bone development, bone remodeling and osteoporosis. Pharm Ther. 2022;238:108174.
Zeng Q, Li N, Wang Q, Feng J, Sun D, Zhang Q, et al. The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey. J Bone Min Res. 2019;34:1789–97.
Chen YW, Ramsook AH, Coxson HO, Bon J, Reid WD. Prevalence and risk factors for osteoporosis in individuals with COPD: a systematic review and meta-analysis. Chest 2019;156:1092–110.
Baker R, Narla R, Baker JF, Wysham KD. Risk factors for osteoporosis and fractures in rheumatoid arthritis. Best Pr Res Clin Rheumatol. 2022;36:101773.
Rossi LMM, Copes RM, Dal Osto LC, Flores C, Comim FV, Premaor MO. Factors related with osteoporosis treatment in postmenopausal women. Medicine. 2018;97:e11524.
Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010;31:266–300.
Wang YF, Chang YY, Zhang XM, Gao MT, Zhang QL, Li X, et al. Salidroside protects against osteoporosis in ovariectomized rats by inhibiting oxidative stress and promoting osteogenesis via Nrf2 activation. Phytomedicine. 2022;99:154020.
Zou DB, Mou Z, Wu W, Liu H. TRIM33 protects osteoblasts from oxidative stress-induced apoptosis in osteoporosis by inhibiting FOXO3a ubiquitylation and degradation. Aging Cell. 2021;20:e13367.
Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021;20:689–709.
Kimball JS, Johnson JP, Carlson DA. Oxidative stress and osteoporosis. J Bone Jt Surg Am. 2021;103:1451–61.
van der Pol A, van Gilst WH, Voors AA, van der Meer P. Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail. 2019;21:425–35.
Lin T, Zhang Z, Wu J, Jiang H, Wang C, Ma J, et al. A ROS/GAS5/SIRT1 reinforcing feedback promotes oxidative stress-induced adipogenesis in bone marrow-derived mesenchymal stem cells during osteoporosis. Int Immunopharmacol. 2023;114:109560.
Zhou W, Liu Y, Shen J, Yu B, Bai J, Lin J, et al. Melatonin Increases bone mass around the prostheses of OVX rats by ameliorating mitochondrial oxidative stress via the SIRT3/SOD2 signaling pathway. Oxid Med Cell Longev. 2019;2019:4019619.
Lee S, Le NH, Kang D. Melatonin alleviates oxidative stress-inhibited osteogenesis of human bone marrow-derived mesenchymal stem cells through AMPK activation. Int J Med Sci. 2018;15:1083–91.
Deng X, Jing D, Liang H, Zheng D, Shao Z. H(2)O(2) damages the stemness of rat bone marrow-derived mesenchymal stem cells: developing a “stemness loss” model. Med Sci Monit. 2019;25:5613–20.
Shaw P, Chattopadhyay A. Nrf2-ARE signaling in cellular protection: mechanism of action and the regulatory mechanisms. J Cell Physiol. 2020;235:3119–30.
Kubo Y, Wruck CJ, Fragoulis A, Drescher W, Pape HC, Lichte P, et al. Role of nrf2 in fracture healing: clinical aspects of oxidative stress. Calcif Tissue Int. 2019;105:341–52.
Ibáñez L, Ferrándiz ML, Brines R, Guede D, Cuadrado A, Alcaraz MJ. Effects of Nrf2 deficiency on bone microarchitecture in an experimental model of osteoporosis. Oxid Med Cell Longev. 2014;2014:726590.
Chen W, Lv N, Liu H, Gu C, Zhou X, Qin W, et al. Melatonin improves the resistance of oxidative stress-induced cellular senescence in osteoporotic bone marrow mesenchymal stem cells. Oxid Med Cell Longev. 2022;2022:7420726.
Liu X, Tao J, Yao Y, Yang P, Wang J, Yu M, et al. Resveratrol induces proliferation in preosteoblast cell MC3T3-E1 via GATA-1 activating autophagy. Acta Biochim Biophys Sin. 2021;53:1495–504.
Kopytko P, Piotrowska K, Janisiak J, Tarnowski M. Garcinol-A natural histone acetyltransferase inhibitor and new anti-cancer epigenetic drug. Int J Mol Sci. 2021;22:2828.
Liu C, Ho PC, Wong FC, Sethi G, Wang LZ, Goh BC. Garcinol: current status of its anti-oxidative, anti-inflammatory and anti-cancer effects. Cancer Lett. 2015;362:8–14.
Jia Y, Jiang J, Lu X, Zhang T, Zhao K, Han W, et al. Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism. J Cell Physiol. 2019;234:7498–509.
Cai B, Ma W, Bi C, Yang F, Zhang L, Han Z, et al. Long noncoding RNA H19 mediates melatonin inhibition of premature senescence of c-kit(+) cardiac progenitor cells by promoting miR-675. J Pineal Res. 2016;61:82–95.
Zhao B, Peng Q, Wang D, Zhou R, Wang R, Zhu Y, et al. Leonurine protects bone mesenchymal stem cells from oxidative stress by activating mitophagy through PI3K/Akt/mTOR pathway. Cells. 2022;11:1724.
He R, Cui M, Lin H, Zhao L, Wang J, Chen S, et al. Melatonin resists oxidative stress-induced apoptosis in nucleus pulposus cells. Life Sci. 2018;199:122–30.
Tang Z, Hu B, Zang F, Wang J, Zhang X, Chen H. Nrf2 drives oxidative stress-induced autophagy in nucleus pulposus cells via a Keap1/Nrf2/p62 feedback loop to protect intervertebral disc from degeneration. Cell Death Dis. 2019;10:510.
Peng H, Yang M, Guo Q, Su T, Xiao Y, Xia ZY. Dendrobium officinale polysaccharides regulate age-related lineage commitment between osteogenic and adipogenic differentiation. Cell Prolif. 2019;52:e12624.
Badila AE, Radulescu DM, Ilie A, Niculescu AG, Grumezescu AM, Radulescu AR. Bone Regeneration and Oxidative Stress: An Updated Overview. Antioxidants. 2022;11:318.
Agidigbi TS, Kim C. Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int J Mol Sci. 2019;20:3576.
Huang L, Su W, Wu Z, Zheng L, Lv C. Glucosamine suppresses oxidative stress and induces protective autophagy in osteoblasts by blocking the ROS/Akt/mTOR signaling pathway. Cell Biol Int. 2022;46:829–39.
Yang R, Zhang J, Li J, Qin R, Chen J, Wang R, et al. Inhibition of Nrf2 degradation alleviates age-related osteoporosis induced by 1,25-Dihydroxyvitamin D deficiency. Free Radic Biol Med. 2022;178:246–61.
Wang J, Wu M, Zheng D, Zhang H, Lv Y, Zhang L, et al. Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-beta1 signaling pathways. Acta Pharm Sin. 2020;41:82–92.
Deb S, Phukan BC, Mazumder MK, Dutta A, Paul R, Bhattacharya P, et al. Garcinol, a multifaceted sword for the treatment of Parkinson’s disease. Neurochem Int. 2019;128:50–7.
Son SI, Su D, Ho TT, Lin H. Garcinol Is an HDAC11 Inhibitor. ACS Chem Biol. 2020;15:2866–71.
Chang NC, Yeh CT, Lin YK, Kuo KT, Fong IH, Kounis NG, et al. Garcinol attenuates lipoprotein(a)-induced oxidative stress and inflammatory cytokine production in ventricular cardiomyocyte through alpha7-nicotinic acetylcholine receptor-mediated inhibition of the p38 MAPK and NF-kappaB signaling pathways. Antioxidants. 2021;10:461.
Kim JY, Jo J, Leem J, Park KK. Inhibition of p300 by garcinol protects against cisplatin-induced acute kidney injury through suppression of oxidative stress, inflammation, and tubular cell death in mice. Antioxididants. 2020;9:1271.
Lu J, Zhang Y, Liang J, Diao J, Liu P, Zhao H. Role of exosomal MicroRNAs and their crosstalk with oxidative stress in the pathogenesis of osteoporosis. Oxid Med Cell Longev. 2021;2021:6301433.
Tao ZS, Li TL, Wei S. Probucol promotes osteoblasts differentiation and prevents osteoporosis development through reducing oxidative stress. Mol Med. 2022;28:75.
Zhu C, Shen S, Zhang S, Huang M, Zhang L, Chen X. Autophagy in bone remodeling: a regulator of oxidative stress. Front Endocrinol. 2022;13:898634.
Lee CW, Lin HC, Wang BY, Wang AY, Shin RL, Cheung SYL, et al. Ginkgolide B monotherapy reverses osteoporosis by regulating oxidative stress-mediated bone homeostasis. Free Radic Biol Med. 2021;168:234–46.
Jie J, Li W, Wang G, Xu X. FK506 ameliorates osteoporosis caused by osteoblast apoptosis via suppressing the activated CaN/NFAT pathway during oxidative stress. Inflamm Res. 2021;70:789–97.
Geng Q, Wang S, Heng K, Zhai J, Song X, Xia L, et al. Astaxanthin attenuates irradiation-induced osteoporosis in mice by inhibiting oxidative stress, osteocyte senescence, and SASP. Food Funct. 2022;13:11770–9.
Niture SK, Khatri R, Jaiswal AK. Regulation of Nrf2-an update. Free Radic Biol Med. 2014;66:36–44.
Dodson M, de la Vega MR, Cholanians AB, Schmidlin CJ, Chapman E, Zhang DD. Modulating NRF2 in disease: timing is everything. Annu Rev Pharm Toxicol. 2019;59:555–75.
Schmidlin CJ, Shakya A, Dodson M, Chapman E, Zhang DD. The intricacies of NRF2 regulation in cancer. Semin Cancer Biol. 2021;76:110–9.
Yang F, Yang L, Li Y, Yan G, Feng C, Liu T, et al. Melatonin protects bone marrow mesenchymal stem cells against iron overload-induced aberrant differentiation and senescence. J Pineal Res. 2017;63:e12422. https://doi.org/10.1111/jpi.12422. Epub 20 Jun 2017.
Noh YH, Kim KY, Shim MS, Choi SH, Choi S, Ellisman MH, et al. Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes. Cell Death Dis. 2013;4:e820.
Wang ZH, Liu JL, Wu L, Yu Z, Yang HT. Concentration-dependent wrestling between detrimental and protective effects of H2O2 during myocardial ischemia/reperfusion. Cell Death Dis. 2014;5:e1297.
Jin ZH, Wang SF, Liao W. Zoledronic acid accelerates osteogenesis of bone marrow mesenchymal stem cells by attenuating oxidative stress via the SIRT3/SOD2 pathway and thus alleviates osteoporosis. Eur Rev Med Pharm Sci. 2020;24:2095–101.
Padhye S, Ahmad A, Oswal N, Sarkar FH. Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs. J Hematol Oncol. 2009;2:38.
Hong J, Sang S, Park HJ, Kwon SJ, Suh N, Huang MT, et al. Modulation of arachidonic acid metabolism and nitric oxide synthesis by garcinol and its derivatives. Carcinogenesis. 2006;27:278–86.
Jing Y, Ai Q, Lin L, Dai J, Jia M, Zhou D, et al. Protective effects of garcinol in mice with lipopolysaccharide/D-galactosamine-induced apoptotic liver injury. Int Immunopharmacol. 2014;19:373–80.
Zou J, Du J, Tu H, Chen H, Cong K, Bi Z, et al. Resveratrol benefits the lineage commitment of bone marrow mesenchymal stem cells into osteoblasts via miR-320c by targeting Runx2. J Tissue Eng Regen Med. 2021;15:347–60.
Acknowledgements
We thank Chubo Xie (Sun Yat-Sen University) for the assistance in the pictures of the schematic diagram. The Fig. 7 was created and exported by using BioRender program (https://www.biorender.com).
Funding
This work was funded by the Natural Science Foundation of Heilongjiang Province (No. LH2021H053) and the Primary Health Care Foundation of China (No. 2022HX029).
Author information
Authors and Affiliations
Contributions
JZ (Jilong Zou), HC, and XF performed the experiments and analyzed the data. JZ (Jilong Zou) drafted the manuscript. JS revised the manuscript and designed the study. ZQ and JZ (Jiale Zhang) assisted in the data collection, data analysis and the experimental design. All authors reviewed and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
All procedures have been approved by the Ethics Committee of the First Affiliated Hospital of Harbin Medical University (2022071).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zou, J., Chen, H., Fan, X. et al. Garcinol prevents oxidative stress-induced bone loss and dysfunction of BMSCs through NRF2-antioxidant signaling. Cell Death Discov. 10, 82 (2024). https://doi.org/10.1038/s41420-024-01855-1
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41420-024-01855-1
- Springer Nature Limited